Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Onconetix, Inc. (ONCO) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Onconetix, Inc. (ONCO), most recent 12 months reported: revenue $645.82K, net loss $10.2M. Latest balance sheet on file: liquid cash $5.94M. From SEC filings. Others in Pharmaceutical Preparations: MEDICINOVA, INC. · SCIENTURE HOLDINGS, INC. · BioXcel Therapeutics, Inc. · RALLYBIO CORPORATION · Silence Therapeutics plc · YARROW BIOSCIENCE, INC. · Quantum Cyber N.V. · MEREO BIOPHARMA GROUP PLC

Stock screener

Watchlist